Skip to main content

Peer Review reports

From: Durvalumab-induced thyroiditis in a patient with non-small cell lung carcinoma: a case report and review of pathogenic mechanisms

Original Submission
29 Aug 2021 Submitted Original manuscript
13 Jan 2022 Reviewed Reviewer Report - Robert Pichler
14 Jan 2022 Reviewed Reviewer Report
20 Mar 2022 Author responded Author comments - Jeroen M.K. de Filette
Resubmission - Version 2
20 Mar 2022 Submitted Manuscript version 2
8 Apr 2022 Reviewed Reviewer Report
11 Apr 2022 Reviewed Reviewer Report - Robert Pichler
24 May 2022 Author responded Author comments - Jeroen M.K. de Filette
Resubmission - Version 3
24 May 2022 Submitted Manuscript version 3
22 Oct 2022 Author responded Author comments - Jeroen M.K. de Filette
Resubmission - Version 4
22 Oct 2022 Submitted Manuscript version 4
Publishing
26 Oct 2022 Editorially accepted
22 Nov 2022 Article published 10.1186/s12902-022-01190-5

You can find further information about peer review here.

Back to article page